Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Express Scripts/Medco's Broad Reach Could Reshape Specialty Benefit Dynamics

Executive Summary

If it wins Federal Trade Commission approval, the proposed merger of Express Scripts Inc. and Medco Health Solutions Inc. would play out against a market driven in large part by high-priced specialty products and rampant genericization.
Advertisement

Related Content

Express Scripts-Medco Merger Closes With No Divestitures Needed
Express Scripts-Medco Deal Fits Post-Health Reform Realities, But Was Hastened By Contract Losses
Express Scripts-Medco Deal Fits Post-Health Reform Realities, But Was Hastened By Contract Losses
What New Cancer Pathway Programs Mean For The Drug Industry
What New Cancer Pathway Programs Mean For The Drug Industry
Cost Containment For Specialty Products Is New Horizon For PBMs

Topics

Advertisement
UsernamePublicRestriction

Register

PS053685

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel